Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Disease

Official title: Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease Without or With Mild Pulmonary Hypertension

Run by Amsterdam UMC, location VUmc · NCT06090838 · Data updated 2026-11-12

This study tests if Balloon Pulmonary Angioplasty can improve the quality of life and exercise ability for people with chronic thromboembolic pulmonary disease who don't have high blood pressure in their lungs.

More Chronic Thromboembolic Pulmonary Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorAmsterdam UMC, location VUmc
Academic / other
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedJune 15, 2023
Main results expectedOctober 31, 2025
Study endsOctober 31, 2027
Registry record updatedOctober 19, 2023
Trial IDNCT06090838 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18-80 with a history of acute pulmonary embolism and persistent functional limitations.

Probably not a fit

Patients with pulmonary hypertension or those who do not meet the specific inclusion criteria will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effects of Balloon Pulmonary Angioplasty (BPA) on quality of life and exercise capacity in patients suffering from chronic thromboembolic pulmonary disease (CTEPD) without pulmonary hypertension. It employs a randomized, cross-over design where participants will first receive BPA treatment or serve as controls, followed by assessments of their quality of life and exercise performance. The study aims to determine the therapeutic effects of BPA and the optimal timing for the intervention, using various clinical assessments and questionnaires throughout the trial period.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life and physical capabilities of patients with CTEPD.

How similar studies have gone: While there have been studies on BPA for other conditions, this specific approach for CTEPD without PH is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* acute pulmonary embolism at least 3 months prior to inclusion and adequately treated
* persistent functional limitations: (New York Heart Association (NYHA) class ≥2)
* persistent radiological perfusion defects: ≥ 3 segmental perfusion defects
* CPET result with:

  1. at least 2 of the following criteria:

     * peak VO2 \< 80%;
     * peak O2 pulse \< 80% of predicted;
     * V'E/V'CO2 @ nadir \> 34;
     * Vd/Vt increasing until peak exercise or peak Vd/Vt \> 0;4;
     * gradual drop of SpO2 of ≥ 3%;
  2. these exercise findings cannot be explained otherwise 2. patients completed a pulmonary rehabilitation program of at least 8 weeks no longer than 2 months before randomization.

     3\. exercise tests were performed after the pulmonary rehabilitation program 4. age 18-80 years 5. Clinical Frailty Scale (CFS) score \< 5 (CFS is a 9-point scale that summarizes the overall level of fitness or frailty of an older adult) 6. written informed consent 7. prior treatment or restart therapeutic dose of anticoagulation treatment before randomization

     Exclusion Criteria:
     1. history of balloon pulmonalis angiography (BPA) or pulmonary endarterectomy
     2. residual thrombi that are not eligible for BPA
     3. major acute or chronic cardiopulmonary comorbidities with an expected impact on survival, exercise capacity and/or gas exchange, e.g. significant coronary heart disease, diastolic/systolic heart failure, pulmonary hypertension (mPAP \> 25 mmHg), severe chronic obstructive pulmonary disease (COPD) GOLD class ≥3, interstitial lung disease (ILD), disabling neuromuscular disease, malignancy
     4. inability to undergo exercise tests
     5. contrast allergy
     6. creatinine clearance \< 30ml/min
     7. pregnancy or breastfeeding

Where it's running

  • Amsterdam UMC
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.